Why Palantir Technologies Stock Crashed on Thursday Yahoo Finance Prediction: This Will Be Palantir Technologies' Stock Price in 2030 The Motley Fool Why Michael Burry remains skeptical around the AI trade, Palantir Yahoo Finance
Why Palantir Technologies Stock Crashed on Thursday Yahoo Finance Prediction: This Will Be Palantir Technologies' Stock Price in 2030 The Motley Fool Why Michael Burry remains skeptical around the AI trade, Palantir Yahoo Finance
At first blush, there doesn’t appear to be a whole lot happening with the S&P 500 in 2026. But dig a little bit deeper, and it is a whole different story.
At first blush, there doesn’t appear to be a whole lot happening with the S&P 500 in 2026. But dig a little bit deeper, and it is a whole different story.
The stock market is going through turbulence driven by two conflicting ideas about the AI trade. On the one hand, investors seem worried that big AI companies like Amazon (NASDAQ: AMZN) and Microsoft (NASDAQ: MSFT) are spending too much money on AI data centers and other AI-related capital expenditures (capex). Amazon's stock recently dropped after the company announced plans to spend $200 billion...
The stock market is going through turbulence driven by two conflicting ideas about the AI trade. On the one hand, investors seem worried that big AI companies like Amazon (NASDAQ: AMZN) and Microsoft (NASDAQ: MSFT) are spending too much money on AI data centers and other AI-related capital expenditures (capex). Amazon's stock recently dropped after the company announced plans to spend $200 billion on AI-related capex in 2026. The stock is down about 9% year to date as I write this and 12% in the past year. Microsoft stock is also getting hit by AI doubts. On Jan. 28, the company reported strong quarterly earnings with a 17% year-over-year increase in revenue and a 21% year-over-year increase in operating income. But the stock went down the next day, driven by concerns about the company's plans to spend more than $100 billion on capex this year. Microsoft stock is down 17% year to date, and about 3.5% in the past year. Continue reading
Why Palantir Technologies Stock Crashed on Thursday Nasdaq Prediction: This Will Be Palantir Technologies' Stock Price in 2030 The Motley Fool World's Biggest Wealth Fund Just Snubbed Michael Burry's Palantir Warning Yahoo Finance
Why Palantir Technologies Stock Crashed on Thursday Nasdaq Prediction: This Will Be Palantir Technologies' Stock Price in 2030 The Motley Fool World's Biggest Wealth Fund Just Snubbed Michael Burry's Palantir Warning Yahoo Finance
March NY world sugar #11 (SBH26 ) today is down -0.06 (-0.43%), and March London ICE white sugar #5 (SWH26 ) is down -8.20 (-2.12%). Sugar prices extended their 5-month-long plunge today and posted 5.25-year nearest-futures lows. Concerns that a global sugar surplus will persist are hammering prices. Last Wednesday,...
March NY world sugar #11 (SBH26 ) today is down -0.06 (-0.43%), and March London ICE white sugar #5 (SWH26 ) is down -8.20 (-2.12%). Sugar prices extended their 5-month-long plunge today and posted 5.25-year nearest-futures lows. Concerns that a global sugar surplus will persist are hammering prices. Last Wednesday,...
Russia To Send Oil To Cuba Amid US-Imposed Blockade Russia is preparing to rush urgently needed oil to Cuba under what officials describe as a "humanitarian" arrangement, according to a report Thursday by the pro-government newspaper Izvestia . The Russian Embassy in Havana told Izvestia that "as far as we know, Russia is expected to supply oil and petroleum products to Cuba as humanitarian aid in...
Russia To Send Oil To Cuba Amid US-Imposed Blockade Russia is preparing to rush urgently needed oil to Cuba under what officials describe as a "humanitarian" arrangement, according to a report Thursday by the pro-government newspaper Izvestia . The Russian Embassy in Havana told Izvestia that "as far as we know, Russia is expected to supply oil and petroleum products to Cuba as humanitarian aid in the near future " - amid the island's worst energy crunch in years. Adobe stock After decades of already crippling sanctions, President Trump's latest Executive Order "imposes a new tariff system that allows the United States to impose additional tariffs on imports from any country that directly or indirectly provides oil to Cuba." The most devastating move has been to block the ability of the post-Maduro Venezuelan government to send supplies to Cuba. Caracas was Cuba's chief oil supplier. Key airlines have stopped flights into Havana's main international airport for lack of jet fuel. As we reported earlier , Russia is allowing its airlines to temporarily operate outbound flights only. 5,000 Russian tourists remain stranded in Cuba , amid an evacuation overseen by Moscow, according to AFP citing Russia's Association of Tour Operators. Earlier this month international reports said Cuba was merely days from running out of fuel, and widescale power outages across various districts of the country have only worsened. " The last known delivery came via a tanker from Mexico in early January , but Mexico halted exports amid US pressure," The Guardian notes. "At the same time, crude flows from Venezuela have dried up after a US operation in January that resulted in the capture of Nicolás Maduro, cutting off support from Cuba’s most trusted energy supplier." Havana's lone primary international airport has seen drastic developments such as the following : In recent hours, a video has gone viral on social media showing dozens of tourists disembarking from a plane on the tarmac in Mos...
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks are selling off Thursday, with the Dow Jones Industrial Average , S & P 500 and Nasdaq all down more than 1%. When the market was on a steadier footing early in the session, we said on the Morning Meeting that we planned ...
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks are selling off Thursday, with the Dow Jones Industrial Average , S & P 500 and Nasdaq all down more than 1%. When the market was on a steadier footing early in the session, we said on the Morning Meeting that we planned to take some profits and raise cash in a market that was beginning to look overbought. Sure enough, the market tumbled shortly after our program ended. Fortunately, we were still able to lock in profits in Eaton and Procter & Gamble into their double-digit percentage gains this year. To answer the question of why the market moved sharply lower, there's fear across numerous industries about AI disruption. It's hitting software again, the financials , office real estate stocks, and even trucking and logistics names. AI models are getting smarter and becoming more advanced by the day, and investors would rather shoot first and sell stocks that may be in crosshairs before finding out how real the risks are. One tech stock hanging in during the broader sell-off was Alphabet . The stock edged higher Thursday after the company announced what it called a major upgrade to its Gemini 3 Deep Think reasoning model. Google said the latest version of Deep Think can now solve modern science, research, and engineering challenges. It's the latest sign that Alphabet has the lead in the ongoing AI frontier model horse race. We made one small buy of Alphabet this Tuesday, and we're interested in adding again on weakness, as indicated earlier Thursday. Existing home sales in January fell 8.4% month over month to a seasonally adjusted rate of 3.91 million, the National Association of Realtors said Thursday morning. Sales were 4.4% lower than in January 2025. For comparison, in December, sales were up 5.1% from the prior month to a seasonally adjusted rate of 4.35 million; and on an annual basis,...
NiSource Inc. recently reported fourth-quarter 2025 results showing sales of US$1,891.4 million and net income of US$249.2 million, with diluted EPS from continuing operations of US$0.51, alongside full-year revenue of US$6,642.2 million and net income of US$929.5 million. Alongside beating analyst earnings expectations, NiSource reaffirmed its 2026 adjusted EPS guidance and outlined about US$28.0...
NiSource Inc. recently reported fourth-quarter 2025 results showing sales of US$1,891.4 million and net income of US$249.2 million, with diluted EPS from continuing operations of US$0.51, alongside full-year revenue of US$6,642.2 million and net income of US$929.5 million. Alongside beating analyst earnings expectations, NiSource reaffirmed its 2026 adjusted EPS guidance and outlined about US$28.00 billion of planned 2026–2030 investments, including nearly US$7.00 billion directed to data...
Anthropic ( ANTHRO ) confirmed on Thursday that it has closed its oft-speculated latest funding round, raising more money than expected. The maker of the Claude family of artificial intelligence models raised $30B in a Series G funding round at a $380B valuation. The round was co-led by D. E. Shaw Ventures, Dragoneer, Founders Fund, ICONIQ, and MGX, Anthropic said in a statement. It also includes ...
Anthropic ( ANTHRO ) confirmed on Thursday that it has closed its oft-speculated latest funding round, raising more money than expected. The maker of the Claude family of artificial intelligence models raised $30B in a Series G funding round at a $380B valuation. The round was co-led by D. E. Shaw Ventures, Dragoneer, Founders Fund, ICONIQ, and MGX, Anthropic said in a statement. It also includes several asset managers, hedge funds, and venture capital firms, as well as some of the previous money that came from Microsoft ( MSFT ) and Nvidia ( NVDA ). Anthropic said the money will be used for "the frontier research, product development, and infrastructure expansions that have made Anthropic the market leader in enterprise AI and coding." “Whether it is entrepreneurs, startups, or the world’s largest enterprises, the message from our customers is the same: Claude is increasingly becoming more critical to how businesses work,” said Krishna Rao, Anthropic’s Chief Financial Officer. “This fundraising reflects the incredible demand we are seeing from these customers, and we will use this investment to continue building the enterprise-grade products and models they have come to depend on.” In addition, Anthropic said that the company's revenue run rate is now $14B, and this figure has grown more than 10 times annually over the past three years. Anthropic's revenue run rate surpassed $9B at the end of 2025, according to previous reporting . Included in that is a surge in Claude Code, the company's agentic AI coding tool. Claude Code's revenue run rate is now more than $2.5B and has more than doubled since the start of the year, Anthropic added. Weekly active users for Claude Code have also doubled since Jan. 1, Anthropic explained. "Business subscriptions to Claude Code have quadrupled since the start of 2026, and enterprise use has grown to represent over half of all Claude Code revenue," Anthropic said. Anthropic, which competes with OpenAI ( OPENAI ) and xAI ( X.AI ), ha...
watch now Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email Power Lunch Bill to fund DHS fails in the Senate CNBC's Emily Wilkins reports on news regarding Congress. 01:15 6 minutes ago Emily Wilkins
watch now Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email Power Lunch Bill to fund DHS fails in the Senate CNBC's Emily Wilkins reports on news regarding Congress. 01:15 6 minutes ago Emily Wilkins
Earnings Call Insights: West Pharmaceutical Services (WST) Q4 2025 Management View CEO Eric Green reported "another solid quarter with fourth quarter revenues, adjusted EPS and cash flow coming in above our expectations," highlighting that the company "surpassed the $3 billion mark in net sales, achieving year-over-year organic growth of over 4%." He outlined the achievement of 8% adjusted earning...
Earnings Call Insights: West Pharmaceutical Services (WST) Q4 2025 Management View CEO Eric Green reported "another solid quarter with fourth quarter revenues, adjusted EPS and cash flow coming in above our expectations," highlighting that the company "surpassed the $3 billion mark in net sales, achieving year-over-year organic growth of over 4%." He outlined the achievement of 8% adjusted earnings per share growth and a 70% increase in free cash flow for the year. Green emphasized that "growth was fueled by increasing demand for high-value product components" and cited key drivers: the rise of biologics and biosimilars, increased global regulatory requirements such as Annex 1, and the expanding GLP-1 market. Green stated the launch of the West Synchrony prefillable syringe system "marks a significant shift in drug delivery solutions" and noted the sale of the SmartDose 3.5mL business aligns with their focus on "patient-centric approach for large on-body delivery devices." The CEO announced that the Contract Manufacturing segment commenced commercial production in Dublin and highlighted that "5 out of the 10 members" of the executive leadership team joined in the last 12 months. CFO Robert McMahon reported, "Q4 revenue increased 7.5% on a reported basis and grew 3.3% organically," with HVP components delivering $390 million in revenue and growing 15.1% organically. He also stated, "Gross margin was 37.8% in the quarter, up 130 basis points year-over-year," and "free cash flow to $469 million for the year, up 70% year-on-year." Outlook Management guided for 2026 revenue in the range of $3.215 billion to $3.275 billion, reflecting reported growth of 4.6% to 6.5% and organic growth of 5% to 7%. HVP components are expected to "grow high single digit to low double digits organically for the year." McMahon explained, "We expect the non-GLP-1 HVP components to drive the majority of growth, accounting for 4 of the 5 points of growth." He added, "GLP-1s to grow in 2026, albe...
Cargill Inc. is permanently closing a plant that produces ground beef in Milwaukee, resulting in the elimination of 221 jobs, according to a notice . The move comes as the US cattle herd has dropped to the lowest in 75 years , leaving meatpackers like Cargill with fewer animals to keep plants running. Cargill, one of the world’s largest beef packers, said it would begin winding down production at ...
Cargill Inc. is permanently closing a plant that produces ground beef in Milwaukee, resulting in the elimination of 221 jobs, according to a notice . The move comes as the US cattle herd has dropped to the lowest in 75 years , leaving meatpackers like Cargill with fewer animals to keep plants running. Cargill, one of the world’s largest beef packers, said it would begin winding down production at the plant soon, with a full closing around the end of May. Rival beef producer Tyson Foods Inc. in November said it would close a cattle slaughtering plant in Nebraska while JBS NV said it would close a meat-processing plant in California. “Separations will happen in phases, based on customer and operational needs,” Cargill said in a statement, adding that workers can apply at other plants. Cargill didn’t immediately reply to a request for additional comment.
The Trump administration on Thursday rolled out a much-anticipated effort to repeal what’s known as the endangerment finding, which provides the legal foundation for climate regulations — but analysts are warning that the move is most likely just the start of a long legal battle.
The Trump administration on Thursday rolled out a much-anticipated effort to repeal what’s known as the endangerment finding, which provides the legal foundation for climate regulations — but analysts are warning that the move is most likely just the start of a long legal battle.
solvod/iStock via Getty Images Steady execution on sales and clinical development builds value over time for biotechs but tends to be rather boring from a market sentiment standpoint. Neurocrine Biosciences ( NBIX ) is doing the right things to build value for its shareholders, but 2026 is looking pretty light on sentiment-changing data, and the company is going to have to improve its sales execut...
solvod/iStock via Getty Images Steady execution on sales and clinical development builds value over time for biotechs but tends to be rather boring from a market sentiment standpoint. Neurocrine Biosciences ( NBIX ) is doing the right things to build value for its shareholders, but 2026 is looking pretty light on sentiment-changing data, and the company is going to have to improve its sales execution to drive upside. Neurocrine shares are relatively flat since my last update , underperforming mid-teens appreciation for the biotech sector. Over the past year, the performances are closer, but Neurocrine has underperformed the sector by around 5%. I believe Neurocrine is worth $181.50 per share, but sales execution with Ingrezza and Crenessity has to improve, and I expect the Street to remain concerned about pricing pressures on Ingrezza in the near term. I also see meaningful value in the pipeline, but programs in major depressive disorder and schizophrenia are high-risk, and the company won’t have much meaningful clinical data until 2027. All of that makes for a risk of a value trap where the lack of sentiment-changing data outside of earnings reports leads the shares to drift before a catalyst-rich 2027. A Decent Fourth Quarter Neurocrine’s fourth quarter results were fine, but not anything that will likely change the tone on the stock (guidance is another story, and I’ll get to that soon). Revenue rose 28% year over year, beating by more than 1%, with product revenue up 29%. Ingrezza revenue rose 7% yoy and fell 4% qoq, matching sell-side expectations. The company’s newer drug, Crenessity, saw almost 38% sequential growth, beating by 12%. Gross margin remains ridiculously good (97.8% vs. 98.5% a year ago). R&D spending was in line with expectations (up 42% yoy), while SG&A spending was about 3% higher (up 6% yoy). Operating income (non-GAAP) rose 30% but did miss by about 6%. Neurocrine ended the quarter with $2.5 billion in cash and cash equivalents. Guidance Didn...
Spire Global (NYSE: SPIR) had a tumultuous 2025 that knocked the stock up and down. The price chart has been rocky so far in 2026, too, and investors need to understand the good and bad of this business. Spire owns and operates a constellation of satellites that provide data to customers on a subscription basis. It also commissions the development and launch of customer-owned satellites. These spa...
Spire Global (NYSE: SPIR) had a tumultuous 2025 that knocked the stock up and down. The price chart has been rocky so far in 2026, too, and investors need to understand the good and bad of this business. Spire owns and operates a constellation of satellites that provide data to customers on a subscription basis. It also commissions the development and launch of customer-owned satellites. These spacecraft are packed with sensors that collect nonvisual data from low-Earth orbit. They are useful for coordinating air travel and logistics. They also capture valuable atmospheric and geologic data. Continue reading